Medicare Part D coverage · 0.5 · RxCUI 1605071
0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio]
Per the CMS 2026 Part D formulary file, 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] is covered by 3,862 Medicare Part D plans (76.4% of enrollable products), averaging Tier 4.4, with prior authorization required on 72.9% of covering formularies.
- 76.4%
- Plan coverage
- 3,862
- Plans covering
- T4.4
- Avg tier
- 72.9%
- Prior auth required
What the CMS Formulary Data Shows for 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio]
Per the CMS 2026 Part D formulary file, 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] (RxNorm concept RXCUI 1605071, generic name 0.5) appears on 166 distinct formulary files spanning 3,862 Medicare Part D plan offerings - 76.4% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 4.4.
Real-world access to 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] depends on utilization management as much as tier placement: 72.9% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 8,324 Part D beneficiaries filled 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] in 2023, with total plan-and-beneficiary spending of $47,452,545 and an average per-beneficiary annual cost of $5,700.69. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] today.
Coverage Details
- Formularies covering
- 166
- Plans covering
- 3,862
- Coverage rate
- 76.4%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 72.9% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 8,324
- Total spending
- $47,452,545
- Avg per beneficiary
- $5,700.69
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | Yes | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | Yes | $0 | VA |
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $0 | FL |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | Yes | $0 | NY |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
Show the next 30 plans
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $0 | MO |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | Yes | $0 | CA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | Yes | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $0 | DE |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Provider Partners Texas Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Texas, Inc. | T1 | No | $4.80 | TX |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $13.10 | PA |
| Provider Partners Illinois Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Illinois | T1 | No | $15.20 | IL |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $17.60 | PA |
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $22.70 | NY |
| VIVA Medicare Extra Value (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
| VIVA Medicare Extra Care (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] covered by Medicare Part D?
Yes, 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] is covered by 3,862 Medicare Part D plans (76.4% of all Part D formularies).
What tier is 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] on Medicare Part D plans?
0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] averages Tier 4.4 across Part D plans, ranging from Tier 1 to Tier 6.
Does 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] require prior authorization?
72.9% of Part D formularies require prior authorization for 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio]?
In 2023, total Medicare Part D spending on 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] was $47,452,545, covering 8,324 beneficiaries. The average spend per beneficiary was $5,700.69.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.8 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] T4.4
- 168 HR granisetron 0.129 MG/HR Transdermal System [Sancuso] T4.4
- chenodeoxycholate 250 MG Oral Tablet [Ctexli] T4.4
- maralixibat 10 MG Oral Tablet [Livmarli] T4.4
- sucroferric oxyhydroxide 500 MG Chewable Tablet [Velphoro] T4.4
- 0.8 ML nedosiran 160 MG/ML Prefilled Syringe [Rivfloza] T4.4
Similar prior-authorization rate
- {12 (siponimod 0.25 MG Oral Tablet [Mayzent]) } Pack [Mayzent 2 MG Starter Pack] 73.1% PA
- vigabatrin 500 MG Oral Tablet [Vigadrone] 73.2% PA
- carbinoxamine maleate 4 MG Oral Tablet 73.3% PA
- tretinoin 0.0004 MG/MG Topical Gel 73.3% PA
- siponimod 0.25 MG Oral Tablet [Mayzent] 73.3% PA
- calcium chloride 0.23 MEQ/ML / magnesium chloride 0.53 MEQ/ML / potassium chloride 0.1 MEQ/ML / sodium acetate 1.48 MEQ/ML / sodium chloride 0.27 MEQ/ML Injectable Solution 73.4% PA